Use Case · Pharma R&D

Decision AI for
Pharma R&D

From first target to patent cliff, a drug moves through six stages, and at every one, a decision either gets made well and fast, or it gets made late, wrong, and expensive. Every stage runs on a clock. One of them never stops.

Request a demo

Pharma R&D Decision Lifecycle

Six stages. Every one on a clock.

Six stages from Discovery to Lifecycle Management, each shown with relative severity of cost-of-delay, with Pharmacovigilance marked as perpetual.

Top Line

Faster trials and filing sequencing protect the commercial exclusivity window and time-to-market.

Bottom Line

Preclinical and pharmacovigilance decisions avoid $50–100M+ sunk cost and perpetual compliance exposure.

Strategic

Every case and every trial decision traces to evidence a regulator can audit.

DecisionX

Pharma R&D Decision Lifecycle

Where DecisionX plugs in,
at every stage of the lifecycle.

Each stage below shows the decisions made, the data they run on, what DecisionX solves, and what it costs to get them wrong or make them late.

The System

Why this needs a decision system,
not a dashboard.

Causality

Why enrollment stalled, a case is causal, or a protocol needs to change.

Clinical trials + post-approval: built on diagnosis, not correlation

Self-learning

Every site ranking and ICSR verdict sharpens the next cycle.

+14–15 pts on deviation & timeline reduction, once it compounds

Unified context

CRO, EDC, and eight spontaneous-report sources reconciled first.

One trusted case file before enrollment or ICSR verdicts run

Decision AI for Pharma R&D

Every stage runs on a clock.
Decide before it costs you.

See DecisionX on your trials, your safety cases, your pipeline. First value in 15 days.

Request a demo